{"count": 15, "results": [{"_id": "33915857", "pmid": 33915857, "pmcid": "PMC8066143", "title": "Evaluation of the Effectiveness of Post-Stroke Metformin Treatment Using Permanent Middle Cerebral Artery Occlusion in Rats", "journal": "Pharmaceuticals (Basel)", "authors": ["Zemgulyte G", "Tanaka S", "Hide I", "Sakai N", "Pampuscenko K", "Borutaite V", "Rastenyte D"], "date": "2021-04-01T00:00:00Z", "doi": "10.3390/ph14040312", "meta_date_publication": "2021 Apr 1", "meta_volume": "14", "meta_issue": "4", "meta_pages": "", "score": 50270.402, "text_hl": "The aim of this study was to evaluate the neuroprotective effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment after permanent @<m>DISEASE_Infarction_Middle_Cerebral_Artery</m> @DISEASE_MESH:D020244 @@@middle cerebral artery occlusion@@@ (@<m>DISEASE_Infarction_Middle_Cerebral_Artery</m> @DISEASE_MESH:D020244 @@@pMCAO@@@) without reperfusion in @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Zemgulyte G, Tanaka S, Hide I, Sakai N, Pampuscenko K, Borutaite V, Rastenyte D. Evaluation of the Effectiveness of Post-Stroke Metformin Treatment Using Permanent Middle Cerebral Artery Occlusion in Rats Pharmaceuticals (Basel). 2021 Apr 1;14(4):. PMID: 33915857", "BibTeX": "@article{33915857, title={Evaluation of the Effectiveness of Post-Stroke Metformin Treatment Using Permanent Middle Cerebral Artery Occlusion in Rats}, author={Zemgulyte G and Tanaka S and Hide I and Sakai N and Pampuscenko K and Borutaite V and Rastenyte D}, journal={Pharmaceuticals (Basel)}, volume={14}, number={4}}"}}, {"_id": "33811249", "pmid": 33811249, "pmcid": "PMC8018962", "title": "Metformin prevents stroke damage in non-diabetic female mice with chronic kidney disease", "journal": "Sci Rep", "authors": ["Grissi M", "Boudot C", "Assem M", "Candellier A", "Lando M", "Poirot-Leclercq S", "Boullier A", "Bennis Y", "Lenglet G", "Avondo C", "Lalau JD", "Choukroun G", "Massy ZA", "Kamel S", "Chillon JM", "Hénaut L"], "date": "2021-04-02T00:00:00Z", "doi": "10.1038/s41598-021-86905-9", "meta_date_publication": "2021 Apr 2", "meta_volume": "11", "meta_issue": "1", "meta_pages": "7464", "score": 50265.42, "text_hl": "@SPECIES_10090 @@@Mice@@@ were then allocated to receive @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (200 mg/kg/day) or vehicle for 5 weeks until @DISEASE_Stroke @DISEASE_MESH:D020521 @@@stroke@@@ induction by @<m>DISEASE_Infarction_Middle_Cerebral_Artery</m> @DISEASE_MESH:D020244 @@@transient middle cerebral artery occlusion@@@ (@<m>DISEASE_Infarction_Middle_Cerebral_Artery</m> @DISEASE_MESH:D020244 @@@tMCAO@@@). ", "citations": {"NLM": "Grissi M, Boudot C, Assem M, Candellier A, Lando M, Poirot-Leclercq S, Boullier A, Bennis Y, Lenglet G, Avondo C, Lalau JD, Choukroun G, Massy ZA, Kamel S, Chillon JM, Hénaut L. Metformin prevents stroke damage in non-diabetic female mice with chronic kidney disease Sci Rep. 2021 Apr 2;11(1):7464. PMID: 33811249", "BibTeX": "@article{33811249, title={Metformin prevents stroke damage in non-diabetic female mice with chronic kidney disease}, author={Grissi M and Boudot C and Assem M and Candellier A and Lando M and Poirot-Leclercq S and Boullier A and Bennis Y and Lenglet G and Avondo C and Lalau JD and Choukroun G and Massy ZA and Kamel S and Chillon JM and Hénaut L}, journal={Sci Rep}, volume={11}, number={1}, pages={7464}}"}}, {"_id": "33845479", "pmid": 33845479, "title": "Neuroprotective Effects of Long-Term Metformin Preconditioning on Rats with Ischemic Brain Injuries.", "journal": "Eur Neurol", "authors": ["Wang L", "Wang A", "Guo H", "Zhang Z", "Wang S", "Pei T", "Liu Z", "Yang D", "Liu Y", "Ruan C"], "date": "2021-01-01T00:00:00Z", "doi": "10.1159/000514431", "meta_date_publication": "2021", "meta_volume": "84", "meta_issue": "3", "meta_pages": "212-218", "score": 50264.547, "text_hl": "METHODS: Twenty-five Sprague-Dawley @SPECIES_10116 @@@rats@@@ were randomly divided into 5 groups: sham group, @<m>DISEASE_Infarction_Middle_Cerebral_Artery</m> @DISEASE_MESH:D020244 @@@middle cerebral artery occlusion@@@ (@<m>DISEASE_Infarction_Middle_Cerebral_Artery</m> @DISEASE_MESH:D020244 @@@MCAO@@@) group, normal saline + @<m>DISEASE_Infarction_Middle_Cerebral_Artery</m> @DISEASE_MESH:D020244 @@@MCAO@@@ group, pre- @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@ + @<m>DISEASE_Infarction_Middle_Cerebral_Artery</m> @DISEASE_MESH:D020244 @@@MCAO@@@ group, and 3-MA + @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@ + @<m>DISEASE_Infarction_Middle_Cerebral_Artery</m> @DISEASE_MESH:D020244 @@@MCAO@@@ group. ", "citations": {"NLM": "Wang L, Wang A, Guo H, Zhang Z, Wang S, Pei T, Liu Z, Yang D, Liu Y, Ruan C. Neuroprotective Effects of Long-Term Metformin Preconditioning on Rats with Ischemic Brain Injuries. Eur Neurol. 2021;84(3):212-218. PMID: 33845479", "BibTeX": "@article{33845479, title={Neuroprotective Effects of Long-Term Metformin Preconditioning on Rats with Ischemic Brain Injuries.}, author={Wang L and Wang A and Guo H and Zhang Z and Wang S and Pei T and Liu Z and Yang D and Liu Y and Ruan C}, journal={Eur Neurol}, volume={84}, number={3}, pages={212-218}}"}}, {"_id": "34473417", "pmid": 34473417, "pmcid": "PMC8553305", "title": "Neuroprotective effects of metformin on cerebral ischemia-reperfusion injury by regulating PI3K/Akt pathway", "journal": "Brain Behav", "authors": ["Ruan C", "Guo H", "Gao J", "Wang Y", "Liu Z", "Yan J", "Li X", "Lv H"], "date": "2021-10-01T00:00:00Z", "doi": "10.1002/brb3.2335", "meta_date_publication": "2021 Oct", "meta_volume": "11", "meta_issue": "10", "meta_pages": "e2335", "score": 50247.668, "text_hl": "...@<m>DISEASE_Infarction_Middle_Cerebral_Artery</m> @DISEASE_MESH:D020244 @@@MCAO@@@/R modeling process", "citations": {"NLM": "Ruan C, Guo H, Gao J, Wang Y, Liu Z, Yan J, Li X, Lv H. Neuroprotective effects of metformin on cerebral ischemia-reperfusion injury by regulating PI3K/Akt pathway Brain Behav. 2021 Oct;11(10):e2335. PMID: 34473417", "BibTeX": "@article{34473417, title={Neuroprotective effects of metformin on cerebral ischemia-reperfusion injury by regulating PI3K/Akt pathway}, author={Ruan C and Guo H and Gao J and Wang Y and Liu Z and Yan J and Li X and Lv H}, journal={Brain Behav}, volume={11}, number={10}, pages={e2335}}"}}, {"_id": "25315906", "pmid": 25315906, "pmcid": "PMC4201919", "title": "Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion", "journal": "J Neuroinflammation", "authors": ["Liu Y", "Tang G", "Li Y", "Wang Y", "Chen X", "Gu X", "Zhang Z", "Wang Y", "Yang GY"], "date": "2014-10-15T00:00:00Z", "doi": "10.1186/s12974-014-0177-4", "meta_date_publication": "2014 Oct 15", "meta_volume": "11", "meta_issue": "", "meta_pages": "177", "score": 50078.453, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ attenuates blood-brain barrier disruption in @SPECIES_10090 @@@mice@@@ following @<m>DISEASE_Infarction_Middle_Cerebral_Artery</m> @DISEASE_MESH:D020244 @@@middle cerebral artery occlusion@@@", "citations": {"NLM": "Liu Y, Tang G, Li Y, Wang Y, Chen X, Gu X, Zhang Z, Wang Y, Yang GY. Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion J Neuroinflammation. 2014 Oct 15;11():177. PMID: 25315906", "BibTeX": "@article{25315906, title={Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion}, author={Liu Y and Tang G and Li Y and Wang Y and Chen X and Gu X and Zhang Z and Wang Y and Yang GY}, journal={J Neuroinflammation}, volume={11}, pages={177}}"}}, {"_id": "25026071", "pmid": 25026071, "title": "Metformin promotes focal angiogenesis and neurogenesis in mice following middle cerebral artery occlusion.", "journal": "Neurosci Lett", "authors": ["Liu Y", "Tang G", "Zhang Z", "Wang Y", "Yang GY"], "date": "2014-09-05T00:00:00Z", "doi": "10.1016/j.neulet.2014.07.006", "meta_date_publication": "2014 Sep 5", "meta_volume": "579", "meta_issue": "", "meta_pages": "46-51", "score": 50068.44, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ promotes focal angiogenesis and neurogenesis in @SPECIES_10090 @@@mice@@@ following @<m>DISEASE_Infarction_Middle_Cerebral_Artery</m> @DISEASE_MESH:D020244 @@@middle cerebral artery occlusion@@@.", "citations": {"NLM": "Liu Y, Tang G, Zhang Z, Wang Y, Yang GY. Metformin promotes focal angiogenesis and neurogenesis in mice following middle cerebral artery occlusion. Neurosci Lett. 2014 Sep 5;579():46-51. PMID: 25026071", "BibTeX": "@article{25026071, title={Metformin promotes focal angiogenesis and neurogenesis in mice following middle cerebral artery occlusion.}, author={Liu Y and Tang G and Zhang Z and Wang Y and Yang GY}, journal={Neurosci Lett}, volume={579}, pages={46-51}}"}}, {"_id": "27350579", "pmid": 27350579, "title": "Pre-stroke Metformin Treatment is Neuroprotective Involving AMPK Reduction.", "journal": "Neurochem Res", "authors": ["Deng T", "Zheng YR", "Hou WW", "Yuan Y", "Shen Z", "Wu XL", "Chen Y", "Zhang LS", "Hu WW", "Chen Z", "Zhang XN"], "date": "2016-10-01T00:00:00Z", "doi": "10.1007/s11064-016-1988-8", "meta_date_publication": "2016 Oct", "meta_volume": "41", "meta_issue": "10", "meta_pages": "2719-2727", "score": 50064.207, "text_hl": "In transient @<m>DISEASE_Infarction_Middle_Cerebral_Artery</m> @DISEASE_MESH:D020244 @@@MCAO@@@ @SPECIES_10090 @@@mice@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ showed no neuroprotection even with pretreatment. ", "citations": {"NLM": "Deng T, Zheng YR, Hou WW, Yuan Y, Shen Z, Wu XL, Chen Y, Zhang LS, Hu WW, Chen Z, Zhang XN. Pre-stroke Metformin Treatment is Neuroprotective Involving AMPK Reduction. Neurochem Res. 2016 Oct;41(10):2719-2727. PMID: 27350579", "BibTeX": "@article{27350579, title={Pre-stroke Metformin Treatment is Neuroprotective Involving AMPK Reduction.}, author={Deng T and Zheng YR and Hou WW and Yuan Y and Shen Z and Wu XL and Chen Y and Zhang LS and Hu WW and Chen Z and Zhang XN}, journal={Neurochem Res}, volume={41}, number={10}, pages={2719-2727}}"}}, {"_id": "28634570", "pmid": 28634570, "pmcid": "PMC5467394", "title": "To Use or Not to Use Metformin in Cerebral Ischemia: A Review of the Application of Metformin in Stroke Rodents", "journal": "Stroke Res Treat", "authors": ["Arbeláez-Quintero I", "Palacios M"], "date": "2017-01-01T00:00:00Z", "doi": "10.1155/2017/9756429", "meta_date_publication": "2017", "meta_volume": "2017", "meta_issue": "", "meta_pages": "9756429", "score": 50061.18, "text_hl": "Liu et al. described the protective effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (200 mg/kg intraperitoneally) through altering the blood-brain barrier subsequent to @<m>DISEASE_Infarction_Middle_Cerebral_Artery</m> @DISEASE_MESH:D020244 @@@MCAO@@@ for 90 minutes in @SPECIES_10090 @@@mice@@@ by decreasing its permeability.", "citations": {"NLM": "Arbeláez-Quintero I, Palacios M. To Use or Not to Use Metformin in Cerebral Ischemia: A Review of the Application of Metformin in Stroke Rodents Stroke Res Treat. 2017;2017():9756429. PMID: 28634570", "BibTeX": "@article{28634570, title={To Use or Not to Use Metformin in Cerebral Ischemia: A Review of the Application of Metformin in Stroke Rodents}, author={Arbeláez-Quintero I and Palacios M}, journal={Stroke Res Treat}, volume={2017}, pages={9756429}}"}}, {"_id": "24632338", "pmid": 24632338, "title": "Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia/macrophages and increased angiogenesis and neurogenesis following experimental stroke.", "journal": "Brain Behav Immun", "authors": ["Jin Q", "Cheng J", "Liu Y", "Wu J", "Wang X", "Wei S", "Zhou X", "Qin Z", "Jia J", "Zhen X"], "date": "2014-08-01T00:00:00Z", "doi": "10.1016/j.bbi.2014.03.003", "meta_date_publication": "2014 Aug", "meta_volume": "40", "meta_issue": "", "meta_pages": "131-42", "score": 50058.117, "text_hl": "@SPECIES_10090 @@@Mice@@@ were randomly divided to receive @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ or vehicle daily beginning at 24h after @<m>DISEASE_Infarction_Middle_Cerebral_Artery</m> @DISEASE_MESH:D020244 @@@middle cerebral artery occlusion@@@ (@<m>DISEASE_Infarction_Middle_Cerebral_Artery</m> @DISEASE_MESH:D020244 @@@MCAO@@@). ", "citations": {"NLM": "Jin Q, Cheng J, Liu Y, Wu J, Wang X, Wei S, Zhou X, Qin Z, Jia J, Zhen X. Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia/macrophages and increased angiogenesis and neurogenesis following experimental stroke. Brain Behav Immun. 2014 Aug;40():131-42. PMID: 24632338", "BibTeX": "@article{24632338, title={Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia/macrophages and increased angiogenesis and neurogenesis following experimental stroke.}, author={Jin Q and Cheng J and Liu Y and Wu J and Wang X and Wei S and Zhou X and Qin Z and Jia J and Zhen X}, journal={Brain Behav Immun}, volume={40}, pages={131-42}}"}}, {"_id": "25172433", "pmid": 25172433, "title": "Chronic Metformin Preconditioning Provides Neuroprotection via Suppression of NF-kappaB-Mediated Inflammatory Pathway in Rats with Permanent Cerebral Ischemia.", "journal": "Mol Neurobiol", "authors": ["Zhu XC", "Jiang T", "Zhang QQ", "Cao L", "Tan MS", "Wang HF", "Ding ZZ", "Tan L", "Yu JT"], "date": "2015-08-01T00:00:00Z", "doi": "10.1007/s12035-014-8866-7", "meta_date_publication": "2015 Aug", "meta_volume": "52", "meta_issue": "1", "meta_pages": "375-85", "score": 50057.938, "text_hl": "Male Sprague-Dawley @SPECIES_10116 @@@rats@@@ were treated with vehicle or @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (50 mg/kg daily, i.p.) for 3 weeks and were subjected to permanent @<m>DISEASE_Infarction_Middle_Cerebral_Artery</m> @DISEASE_MESH:D020244 @@@middle cerebral artery occlusion@@@ (@<m>DISEASE_Infarction_Middle_Cerebral_Artery</m> @DISEASE_MESH:D020244 @@@pMCAO@@@). ", "citations": {"NLM": "Zhu XC, Jiang T, Zhang QQ, Cao L, Tan MS, Wang HF, Ding ZZ, Tan L, Yu JT. Chronic Metformin Preconditioning Provides Neuroprotection via Suppression of NF-kappaB-Mediated Inflammatory Pathway in Rats with Permanent Cerebral Ischemia. Mol Neurobiol. 2015 Aug;52(1):375-85. PMID: 25172433", "BibTeX": "@article{25172433, title={Chronic Metformin Preconditioning Provides Neuroprotection via Suppression of NF-kappaB-Mediated Inflammatory Pathway in Rats with Permanent Cerebral Ischemia.}, author={Zhu XC and Jiang T and Zhang QQ and Cao L and Tan MS and Wang HF and Ding ZZ and Tan L and Yu JT}, journal={Mol Neurobiol}, volume={52}, number={1}, pages={375-85}}"}}]}